|

5-FU (5-fluorouracil) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Gruppo Oncologico del Nord-Ovest1
  • Akeso1

Indications

  • Cancer2
  • Pancreatic Adenocarcinoma Advanced or Metastatic1
  • Non-small Cell Lung Cancer Stage IIIB/IV1
  • Colorectal Adenocarcinoma1
  • Head and Neck Squamous Cell Carcinoma (HNSCC)1

Other2 trials

AK129 Combination Therapy for Advanced Solid Tumors
Phase 1/2
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.